ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,332Medicare Part D Prescriptions Filled, Including Refills

Rank: 119 out of 2680

$599K Total Retail Price of All Prescriptions

Rank: 231 out of 2680

212 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

31% of this provider’s 212 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 11,030 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 557 554 1 7
SERTRALINE HCL 510 485 2 23
POLYETHYLENE GLYCOL 3350 500 488 3 55
LEVOTHYROXINE SODIUM 447 436 4 4
METOPROLOL TARTRATE 336 336 5 8
ALBUTEROL SULFATE 300 289 6 97
IPRATROPIUM BROMIDE 277 277 7 157
SIMVASTATIN 274 272 8 1
LISINOPRIL 264 262 9 5
AMLODIPINE BESYLATE 255 255 10 3
POTASSIUM CHLORIDE 233 233 11 29
WARFARIN SODIUM 174 174 12 12
OMEPRAZOLE 168 152 13 2
BRIMONIDINE TARTRATE 164 164 14 322
ATENOLOL 159 159 15 14
ATORVASTATIN CALCIUM 156 156 16 10
GABAPENTIN 150 124 17 21
DONEPEZIL HCL 149 149 18 28
TAMSULOSIN HCL 142 142 19 25
CITALOPRAM HBR 132 119 20 22
METOPROLOL SUCCINATE 124 124 21 11
CARBIDOPA-LEVODOPA 113 103 22 88
TRAZODONE HCL 111 97 23 60
QUETIAPINE FUMARATE 108 108 24 72
DIOVAN 100 100 25 26
BUPROPION HCL 100 87 25 377
OLANZAPINE 100 92 25 128
LATANOPROST 97 97 28 195
ABILIFY 97 97 28 192
TRAVATAN Z 96 96 30 234
NAMENDA 88 88 31 43
FINASTERIDE 80 79 32 80
CARVEDILOL 75 75 33 27
LANTUS 74 73 34 70
OXYCODONE HCL 73 70 S2 35 93
OXYCODONE-ACETAMINOPHEN 73 73 S2 35 106
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 71 37 137
METFORMIN HCL 71 71 38 6
ZOLPIDEM TARTRATE 70 70 39 17
LOVASTATIN 68 68 40 37
LEVOFLOXACIN 67 64 41 108
SANTYL 67 67 41 144
ESCITALOPRAM OXALATE 66 66 43 82
NYSTATIN-TRIAMCINOLONE 63 62 44 140
DIGOXIN 61 61 45 59
PRAVASTATIN SODIUM 61 61 45 16
PAROXETINE HCL 58 58 47 62
LUMIGAN 55 55 48 351
RANITIDINE HCL 53 53 49 35
LAMOTRIGINE 53 45 49 232
SPIRIVA 52 49 51 36
JANUVIA 51 51 52 34
MIRTAZAPINE 50 50 53 48
DORZOLAMIDE-TIMOLOL 50 50 53 470
ALENDRONATE SODIUM 50 50 53 20
NYSTATIN 50 49 53 160
CIPROFLOXACIN HCL 50 48 53 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.